A rapid and systematic review of the clinical effectiveness and cost-effectiveness of capecitabine ( Xeloda ® ) for locally advanced and / or metastatic breast cancer
Westwood, M;
Hawkins, N;
Riemsma, R;
(2003)
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of capecitabine ( Xeloda ® ) for locally advanced and / or metastatic breast cancer.https://researchonline.lshtm.ac.uk/id/eprint/2535033
Permanent Identifier
Use this permanent URL when citing or linking to this resource.
